NCT03837470View on ClinicalTrials.gov

Evaluation of Renal Sodium Excretion After Salt Loading in Heart Failure With Preserved Ejection Fraction

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

May 6, 2019

Primary Completion Date

February 20, 2020

Study Completion Date

February 20, 2020

Conditions
Heart Failure With Preserved Ejection Fraction
Interventions
DRUG

0.9% Sodium Chloride

Intravenous infusion of 0.25ml/kg/min of 0.9% sodium chloride intravenously for a total of 60 minutes

DRUG

Furosemide 40 mg

Bolus intravenous injection of 40 mg furosemide

Trial Locations (1)

84132

University of Utah, Salt Lake City

All Listed Sponsors
collaborator

University of Utah Center for Clinical and Translational Science

UNKNOWN

lead

Adhish Agarwal

OTHER

NCT03837470 - Evaluation of Renal Sodium Excretion After Salt Loading in Heart Failure With Preserved Ejection Fraction | Biotech Hunter | Biotech Hunter